Entering text into the input field will update the search result below

Alexion Pharmaceuticals beats by $0.01, beats on revenue

  • Alexion Pharmaceuticals (NASDAQ:ALXN): Q4 EPS of $1.30 beats by $0.01.
  • Revenue of $599.48M (+35.7% Y/Y) beats by $9.03M.
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
ALXN--
Alexion Pharmaceuticals, Inc.